WO2007046353A1 - 線維芽細胞賦活剤および線維芽細胞賦活方法、コラーゲン合成促進剤およびコラーゲン合成促進方法、ならびに皮膚老化防止剤および皮膚老化防止方法 - Google Patents
線維芽細胞賦活剤および線維芽細胞賦活方法、コラーゲン合成促進剤およびコラーゲン合成促進方法、ならびに皮膚老化防止剤および皮膚老化防止方法 Download PDFInfo
- Publication number
- WO2007046353A1 WO2007046353A1 PCT/JP2006/320614 JP2006320614W WO2007046353A1 WO 2007046353 A1 WO2007046353 A1 WO 2007046353A1 JP 2006320614 W JP2006320614 W JP 2006320614W WO 2007046353 A1 WO2007046353 A1 WO 2007046353A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- collagen synthesis
- skin
- fibroblast
- proline
- aging
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
Definitions
- Fibroblast activator and fibroblast activation method Fibroblast activator and fibroblast activation method, collagen synthesis promoter and collagen synthesis promotion method, skin aging inhibitor and skin aging prevention method
- the present invention relates to a fibroblast activator and a fibroblast activation method for activating fibroblasts involved in collagen degradation and synthesis, a collagen synthesis promoter, a collagen synthesis promotion method, and a fibroblast
- the present invention relates to a skin aging inhibitor and a method for preventing skin aging that can prevent skin aging by activating and promoting collagen synthesis.
- skin aging is a physiological phenomenon that occurs when physiological aging associated with aging and photoaging due to ultraviolet rays influence each other.
- proteins such as collagen that are in the dermis layer and become the source of skin elasticity decrease with age.
- the ability of the fibroblasts themselves to produce collagen declines.
- Photoaging is a phenomenon in which an enzyme that breaks down collagen is secreted when the skin is exposed to ultraviolet rays, causing collagen to break down and the elasticity of the dermis to be lost.
- Such a decrease in the amount of collagen and a decrease in the function of fibroblasts are major factors that cause an aging phenomenon such as shitarami.
- an anti-aging component that suppresses the activity of collagenase (collagenase) as a countermeasure against aging.
- collagenase inhibitor certain types of mushroom extract (Japanese Patent Laid-Open No. 9-40552), extract of Artemisia plant (Japanese Patent Laid-Open No. 10-194982), grape seeds and apple seeds, saxifragaceae plants Whole plant extract (JP-A-11-71294), thyme extract (JP-A-11-79970), eucalyptus, salvia, dokudami, button, peonies extract (JP-A-11-1478) No.
- Retinoleic acid (retinoic acid, vitamin A derivative) is well known as an anti-aging component that promotes collagen synthesis more effectively (Methods in Enzymology, 1990, vo 1.190, p352-360). .
- retinol acid is limited to use by doctors in Japan, where its irritation is strong. Therefore, the development of a highly effective and safe anti-aging agent is eagerly desired.
- an object of the present invention is to provide a safe and effective anti-aging means.
- grape juice has an action of activating fibroblast activation and collagen synthesis of fibroblasts.
- the headline and the present invention were completed.
- the present invention relates to a fibroblast activator containing grape juice as an active ingredient, a fibroblast activation method using grape juice, and a method of using grape juice as a fibroblast activator. .
- the present invention relates to a collagen synthesis promoter containing grape juice as an active ingredient, a method for promoting collagen synthesis using bud juice, and a method of using grape juice as a collagen synthesis promoter. .
- the present invention relates to an anti-skin aging agent containing grape juice as an active ingredient, a method for preventing skin aging using grape juice, and a method of using grape juice as an anti-skin agent.
- collagen synthesis is promoted and skin aging is effectively prevented. Can do. Furthermore, in the present invention, when proline is used in combination with grape sap, the effect of grape sap can be further enhanced.
- the present invention relates to a fibroblast activator containing grape juice as an active ingredient, and the fibroblast activator of the present invention can also contain proline in addition to grape sap.
- the present invention relates to a method for activating fibroblasts using grape juice, and the method for activating fibroblasts of the present invention can also use proline in addition to grape sap.
- the present invention relates to a method of using grape juice as a fibroblast activator.
- the fibroblast activator can contain proline in addition to grape juice.
- Collagen is a fibrous protein present in most cells such as skin, blood vessels, tendons, and teeth, and occupies about 30% of the total protein constituting the human body.
- the human body is made up of more than 60 trillion cell forces.
- Cells and organs made up of cells are correctly shaped by the extracellular matrix.
- Collagen is a protein that constitutes this extracellular matrix, serves as a scaffold for cells, helps maintain its growth and function, and plays an important role as a component of matrix protein in cartilage and bone.
- Fibroblasts are one of the main cells producing collagen. Collagen secreted from fibroblasts fills the space between cells to form an intercellular matrix. As a result of the study by the present inventors, it has been newly found that grape sap has an action of activating the fibroblasts themselves (fibroblast activation action).
- Proline is preferably L-proline.
- the present invention relates to a collagen synthesis promoter containing grape juice as an active ingredient, and the collagen synthesis promoter of the present invention can also contain proline in addition to grape tree sap.
- the present invention relates to a method for promoting collagen synthesis using grape juice, and the method for promoting collagen synthesis of the present invention can also use proline in addition to grape sap.
- the present invention relates to a method of using grape juice as a collagen synthesis promoter, and a method of using the present invention Then, the collagen synthesis promoter may contain proline in addition to grape juice.
- the collagen synthesis promoter of the present invention includes, as an active ingredient, grape grape juice that acts on the fibroblasts themselves, activates the cells themselves, and promotes the collagen synthesis of fibroblasts. In addition, the synthesis of collagen can be effectively promoted.
- Proline is preferably L-proline.
- the present invention relates to a skin aging inhibitor containing grape juice as an active ingredient, and the skin aging inhibitor of the present invention can also contain proline in addition to grape sap.
- the present invention relates to a method for preventing skin aging using grape juice, and the method for preventing skin aging according to the present invention can use proline in addition to grape sap.
- the present invention relates to a method of using grape juice as a skin anti-aging agent. In the method of use of the present invention, the skin anti-aging agent may contain proline in addition to grape juice.
- Grape sap is plant conduit water that flows through the body of a grape (Vitis family) tree.
- the grape sap used in the present invention is not particularly limited as long as it is a sap of a plant belonging to grapes, but a sap of grapes, wild grapes and the like can be used.
- Kyoho, Koshu, Kaiji, Muscat 'Berry A, Delaware, Campbell, Early, Pione, Neo'Muscat, Niagara, Concord, Steuben, Power Berne'Sauvignon, Pinot'Noir Examples include Merlot, Semillon, Riesling and Chardonnay.
- the area where the plant is cultivated, the cultivation method, and the like are not limited, but among them, the sap that overflows from the pruned grape branches before the early spring germination period is preferable.
- Grape sap can be obtained by collecting a sap that flows by cutting a stalk of grapes.
- a small container or the like is attached to a pruned area where the liquid smoke flows, and the liquid flowing out is collected, and this is added to a preservative or the like. This can be done by collecting in a storage container. It is possible to collect the liquid from various positions at a time, for example, using the collection device described in JP-A-10-295207, the liquid receiver described in JP-A-2005-118035, High efficiency is preferable and quality deterioration can be prevented.
- the collected grape sap can be used as a liquid substance by mixing with an antiseptic or the like, if necessary, or can be used as a freeze-dried product.
- the collected grape sap may be subjected to heat treatment and clarification treatment as necessary.
- the heat treatment can be performed by heating the grape juice at, for example, 60 to: LOO ° C, preferably 80 to 90 ° C, for example for 10 minutes or more.
- the heat treatment may be performed on the harvested grape sap or after the product is made.
- the clarification treatment can be performed using a known clarifier such as activated carbon, bentonite, silica gel, silica sol, PVPP (polyvinyl polypyrrolidone) and the like.
- the fibroblast activator, collagen synthesis promoter and skin aging inhibitor of the present invention can all contain grape juice in a liquid form or can be contained as a lyophilized product.
- the dosage form is not particularly limited, and can be provided in various dosage forms such as a lotion, emulsion, gel, cream, ointment, powder, granule and the like.
- the fibroblast activator, collagen synthesis promoter and skin anti-aging agent of the present invention may be grape juice only or It can also consist of dough sap and proline, or, if necessary, oily ingredients, surfactants, moisturizers, pigments, UV absorbers that are usually blended in pharmaceuticals, quasi drugs, skin cosmetics, etc.
- Antioxidants, fragrances, pigments, antibacterial agents, antifungal agents, alcohol, water and the like can be appropriately blended.
- other cell activators, collagen synthesis promoters, and anti-aging agents can be used in combination as long as the effects of the present invention are not impaired.
- the fibroblast activator, the collagen synthesis accelerator, and the skin aging inhibitor of the present invention all contain grape juice in an amount of 1% by mass or more, more preferably 3% by mass in terms of unadjusted solution. It can be contained in an amount of 100% by mass, more preferably 10% by mass to 80% by mass.
- the grape sap itself can be used as a fibroblast activator, a collagen synthesis promoter, and a skin aging inhibitor.
- the compounding amount is 0.1 to 3% by mass, preferably 0. The range of 1 to 1.5% by mass is appropriate.
- the amount of proline is the ratio when the total amount with grape sap is 100% by mass.
- the method of applying the fibroblast activator, collagen synthesis promoter and skin antiaging agent of the present invention as a skin external preparation can be appropriately selected depending on the type of external preparation.
- an external preparation prepared as a lotion, emulsion, gel, cream, ointment it is preferable to apply to the skin such as the face once or twice a day.
- the fibroblast activator, collagen synthesis promoter, and skin aging inhibitor of the present invention can also be used as cosmetics, and can be applied to lotions, emulsions, serums, creams, liquid foundations, powder foundations, lipsticks, and the like.
- the dose is determined based on the age and skin condition of the recipient. It can select suitably according to conditions, such as a state.
- the dosage is, for example, 1 per adult
- the grape sap used in the following examples was spilled from the branches of grapes (variety: Koshu) being pruned in the vineyards of Katsunuma, Higashiyamanashi, Yamanashi, in early April 2005. Was obtained using the apparatus described in JP-A-10-295207, and the freeze-dried product lg of grape sap corresponds to 280 g of unadjusted liquid smoke.
- the formazan produced in the cells was dissolved in 2_propanol, and the absorbance at 550 nm and 650 nm was measured using a microphone plate reader. The amount of formazan produced was evaluated.
- the cell activation activity was expressed as an activation index (%) where the absorbance (ABS.) Of cultured cells without the sample (control) was 100.
- the results are shown in Table 1. All results were expressed as mean standard deviation. Student-t test was used for the significant difference test. The p value was determined to be significant when p was 0.05. As shown in Table 1, it was confirmed that fibroblasts could be activated by culturing in a medium supplemented with grape juice.
- Fibroblast collagen synthesis was evaluated by quantifying type I collagen secreted into the culture supernatant by ELISA.
- the effect was remarkable when a medium containing a freeze-dried grape juice solution of 500 / z gZml or more was used.
- a significant increase in the amount of protein was observed when a medium containing lyophilized grape sap of 250 gZ ml or more was used.
- An increase in protein indicates that fibroblasts are activated and proliferating.
- the amount of collagen shown in Table 2 is the value divided by the amount of protein, and it can be seen that the amount of collagen synthesized by individual cells is also significantly increased.
- the wrinkles on the skin are 40 women in their 60s and 40 women in their 60s.
- the subjects are divided into 4 groups of 10 people so that their ages are not biased. 1 and Examples 1-3
- Each of the subjects in each group used the creams of the four prescription examples in the morning and night twice a day for 30 consecutive days, mainly around the eye where wrinkles easily occur. Comparison was made by visual judgment method using photographs. The results are shown in Table 6.
- the collagen synthesis promoter and fibroblast activator of the present invention are expected to be applied to prevention of aging, acne scars, healing of pregnancy lines, wound treatment such as burns, and promotion of artificial skin culture.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Alternative & Traditional Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Toxicology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/083,834 US20090297645A1 (en) | 2005-10-18 | 2006-10-17 | Fibroblast Activator and Method of Activating Fibroblast, Collagen Synthesis Promoter and Method of Promoting Collagen Synthesis, and Skin Antiaging Agent and Method of Preventing Aging of Skin |
JP2007540972A JPWO2007046353A1 (ja) | 2005-10-18 | 2006-10-17 | 線維芽細胞賦活剤および線維芽細胞賦活方法、コラーゲン合成促進剤およびコラーゲン合成促進方法、ならびに皮膚老化防止剤および皮膚老化防止方法 |
EP06811869A EP1949889A1 (en) | 2005-10-18 | 2006-10-17 | Fibroblast activator, method for activation of fibroblast, collagen synthesis promoter, method for promotion of collagen synthesis, skin aging-preventing agent, and method for prevention of aging of the skin |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005302591 | 2005-10-18 | ||
JP2005-302591 | 2005-10-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007046353A1 true WO2007046353A1 (ja) | 2007-04-26 |
Family
ID=37962446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2006/320614 WO2007046353A1 (ja) | 2005-10-18 | 2006-10-17 | 線維芽細胞賦活剤および線維芽細胞賦活方法、コラーゲン合成促進剤およびコラーゲン合成促進方法、ならびに皮膚老化防止剤および皮膚老化防止方法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20090297645A1 (ja) |
EP (1) | EP1949889A1 (ja) |
JP (1) | JPWO2007046353A1 (ja) |
KR (1) | KR20080068077A (ja) |
CN (1) | CN101299991A (ja) |
WO (1) | WO2007046353A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008053960A1 (fr) * | 2006-11-02 | 2008-05-08 | Mercian Corporation | Accélérateurs de synthèse de céramides, préparation cosmétique, préparation pour la peau pour un usage externe, procédé anti-vieillissement, et procédé de diminution des rides |
WO2009014102A1 (ja) * | 2007-07-23 | 2009-01-29 | Mercian Corporation | レスベラトロールを含有するブドウ樹液 |
JP6491775B1 (ja) * | 2018-04-11 | 2019-03-27 | 株式会社ティーダイレクト | ブドウ由来の新規アラビノガラクタンプロテイン |
JP6988016B1 (ja) * | 2021-04-22 | 2022-01-05 | 佐藤製薬株式会社 | グランザイムb抑制剤 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103237555B (zh) * | 2010-02-19 | 2015-03-11 | 玫琳凯有限公司 | 外用皮肤护理制剂 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11139950A (ja) * | 1997-11-11 | 1999-05-25 | Mercian Corp | ブドウ樹液を含む化粧水 |
JPH11139951A (ja) * | 1997-10-31 | 1999-05-25 | Lion Corp | 化粧料 |
JPH11158055A (ja) * | 1997-11-26 | 1999-06-15 | Noevir Co Ltd | 皮膚外用剤 |
JP2003335619A (ja) * | 2002-05-14 | 2003-11-25 | Noevir Co Ltd | 皮膚外用剤 |
JP2003342123A (ja) * | 2002-05-31 | 2003-12-03 | Ichimaru Pharcos Co Ltd | コラゲナーゼ活性阻害剤、エラスターゼ活性阻害剤及び化粧料組成物 |
JP2005289873A (ja) * | 2004-03-31 | 2005-10-20 | Naris Cosmetics Co Ltd | シワ改善用皮膚外用剤 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1045564A (ja) * | 1996-05-22 | 1998-02-17 | Mercian Corp | 化粧料 |
ATE536858T1 (de) * | 2000-04-18 | 2011-12-15 | Medestea Int Spa | Zubereitung auf basis natürlicher extrakte zur vorbeugung und behandlung von hautfalten |
-
2006
- 2006-10-17 JP JP2007540972A patent/JPWO2007046353A1/ja active Pending
- 2006-10-17 CN CNA2006800390190A patent/CN101299991A/zh active Pending
- 2006-10-17 EP EP06811869A patent/EP1949889A1/en not_active Withdrawn
- 2006-10-17 WO PCT/JP2006/320614 patent/WO2007046353A1/ja active Application Filing
- 2006-10-17 US US12/083,834 patent/US20090297645A1/en not_active Abandoned
- 2006-10-17 KR KR1020087011790A patent/KR20080068077A/ko not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11139951A (ja) * | 1997-10-31 | 1999-05-25 | Lion Corp | 化粧料 |
JPH11139950A (ja) * | 1997-11-11 | 1999-05-25 | Mercian Corp | ブドウ樹液を含む化粧水 |
JPH11158055A (ja) * | 1997-11-26 | 1999-06-15 | Noevir Co Ltd | 皮膚外用剤 |
JP2003335619A (ja) * | 2002-05-14 | 2003-11-25 | Noevir Co Ltd | 皮膚外用剤 |
JP2003342123A (ja) * | 2002-05-31 | 2003-12-03 | Ichimaru Pharcos Co Ltd | コラゲナーゼ活性阻害剤、エラスターゼ活性阻害剤及び化粧料組成物 |
JP2005289873A (ja) * | 2004-03-31 | 2005-10-20 | Naris Cosmetics Co Ltd | シワ改善用皮膚外用剤 |
Non-Patent Citations (4)
Title |
---|
FINERMAN G.A.M. ET AL.: "Amino acid transport in bone. II. regulation of collagen synthesis by perturbation of praline transport", BIOCHIM. BIOPHYS. ACTA, vol. 135, 1967, pages 1008 - 1015, XP003012136 * |
IMAMURA K.: "Budo no Jueki no Himitsu", GENDAI NOGYO, vol. 83, no. 3, 1 March 2004 (2004-03-01), pages 58 - 61, XP003012135 * |
SAWAMA J.T. ET AL.: "Proline in fascioliasis. IV. Induction of bile duct hyperplasia", COMP. BIOCHEM. PHYSIOL., vol. 61A, 1978, pages 239 - 243, XP003012137 * |
See also references of EP1949889A1 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008053960A1 (fr) * | 2006-11-02 | 2008-05-08 | Mercian Corporation | Accélérateurs de synthèse de céramides, préparation cosmétique, préparation pour la peau pour un usage externe, procédé anti-vieillissement, et procédé de diminution des rides |
WO2009014102A1 (ja) * | 2007-07-23 | 2009-01-29 | Mercian Corporation | レスベラトロールを含有するブドウ樹液 |
JPWO2009014102A1 (ja) * | 2007-07-23 | 2010-10-07 | メルシャン株式会社 | レスベラトロールを含有するブドウ樹液 |
JP6491775B1 (ja) * | 2018-04-11 | 2019-03-27 | 株式会社ティーダイレクト | ブドウ由来の新規アラビノガラクタンプロテイン |
JP2019182790A (ja) * | 2018-04-11 | 2019-10-24 | 株式会社ティーダイレクト | ブドウ由来の新規アラビノガラクタンプロテイン |
JP6988016B1 (ja) * | 2021-04-22 | 2022-01-05 | 佐藤製薬株式会社 | グランザイムb抑制剤 |
JP2022166987A (ja) * | 2021-04-22 | 2022-11-04 | 佐藤製薬株式会社 | グランザイムb抑制剤 |
Also Published As
Publication number | Publication date |
---|---|
EP1949889A1 (en) | 2008-07-30 |
KR20080068077A (ko) | 2008-07-22 |
US20090297645A1 (en) | 2009-12-03 |
CN101299991A (zh) | 2008-11-05 |
JPWO2007046353A1 (ja) | 2009-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Castellan et al. | Long-term stability of dentin matrix following treatment with various natural collagen cross-linkers | |
CN104784071B (zh) | 一种皮肤全面抗衰老水凝露及其制备方法 | |
JPH10509735A (ja) | ビタミンc若しくはその誘導体又はそれらの類似体の、皮膚エラスチン合成促進のための使用 | |
JP2002193738A (ja) | 皮膚老化の徴候を処置する組成物における、少なくとも1種のツツジ科植物の少なくとも1種の抽出物の使用 | |
KR20160064410A (ko) | 스피큘을 포함하는 피부관리용 화장품 조성물 및 이의 제조방법 | |
WO2009145419A2 (ko) | 식물성 펩톤을 포함하는 줄기세포 증식 촉진용 조성물 | |
WO2007046353A1 (ja) | 線維芽細胞賦活剤および線維芽細胞賦活方法、コラーゲン合成促進剤およびコラーゲン合成促進方法、ならびに皮膚老化防止剤および皮膚老化防止方法 | |
US6193975B1 (en) | Use of potentilla erecta extract in the cosmetic and pharmaceutical field | |
CN104887542B (zh) | 一种化妆品组合物 | |
CN113332162A (zh) | 一种鱼精蛋白-pdrn复合物、组合物及在制备护肤产品中的应用 | |
CN102421412A (zh) | 含有日本扁柏多糖的皮肤外用组合物 | |
CN110368347A (zh) | 一种抗衰修复双层双色精华素及其制备方法 | |
KR20100096447A (ko) | 돼지 태반 조직 유래 줄기세포의 배양물 및 그 추출 단백질을 함유한 화장료용 조성물 | |
KR20220111000A (ko) | 병풀, 어성초, 산삼, 녹차, 커피, 감나무잎, 카카오, 포도로 구성된 식물 복합체의 에멀젼 추출물을 유효 성분을 함유하는 미백 및 피부주름 개선용 화장료 조성물 | |
KR101859499B1 (ko) | 세포외기질을 모사한 지방유래 줄기세포의 줄기세포성 증진용 조성물 | |
CN115671147B (zh) | 一种海木耳萃取物及其用途 | |
KR101526303B1 (ko) | 항노화용 화장료 조성물 | |
KR101757734B1 (ko) | 세콰이어 캘러스 추출물을 함유하는 지방유래 줄기세포의 줄기세포성 증진용 및 피부세포 증식용 조성물 | |
KR101853719B1 (ko) | 하이페리쿰 추출물을 함유하는 지방유래 줄기세포의 줄기세포성 증진용 및 피부세포 증식용 조성물 | |
WO2009148206A1 (en) | Composition for skin external application containing for improving skin wrinkle or skin whitening | |
JP5155543B2 (ja) | エンドセリン−1産生抑制剤、ヘキソサミニダーゼ遊離抑制剤、抗炎症用/美白用皮膚外用剤、エンドセリン−1の産生抑制方法及びヘキソサミニダーゼの遊離抑制方法 | |
KR20120058830A (ko) | 하이페리쿰 추출물을 함유하는 지방유래 줄기세포의 줄기세포성 증진용 및 피부세포 증식용 조성물 | |
KR102605184B1 (ko) | 동백화밀을 포함하는 항노화용 조성물 | |
Kuria | Efficacy of aspilia pluriseta schweinf in cutaneous wound healing in a mouse model | |
KR101766394B1 (ko) | 하이페리쿰 추출물을 함유하는 지방유래 줄기세포의 줄기세포성 증진용 및 피부세포 증식용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200680039019.0 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2007540972 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006811869 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020087011790 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12083834 Country of ref document: US |